Skip to content
HowShorted

CORCEPT THERAPEUTICS INC short interest in 2024

In 2024, CORCEPT THERAPEUTICS INC's disclosed short interest ran from 15.20% of shares outstanding on 12 Jan 2024 to 15.23% on 31 Dec 2024, a change of +0.03 percentage points. The year's high was 21.85% on 15 Jul 2024 and its low 15.00% on 13 Dec 2024, averaging 19.11% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 45.74 days on 30 Aug 2024. Full history: CORCEPT THERAPEUTICS INC.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for CORCEPT THERAPEUTICS INC in 2024

2024 in figures

Start of year
15.20% (12 Jan 2024)
End of year
15.23% (31 Dec 2024)
Change
+0.03 pp
High
21.85% (15 Jul 2024)
Low
15.00% (13 Dec 2024)
Average
19.11%
Highest days to cover
45.74 (30 Aug 2024)
SEC filings marked
9

Every report in 2024

CORCEPT THERAPEUTICS INC short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 202415.20%6.32results (8-K)
31 Jan 202418.74%7.87
15 Feb 202418.98%13.1710-K filed, results (8-K)
29 Feb 202419.18%16.88
15 Mar 202419.53%21.98
28 Mar 202420.61%25.23
15 Apr 202420.40%28.36
30 Apr 202419.02%15.01
15 May 202419.02%14.6410-Q filed, results (8-K)
31 May 202418.53%17.93
14 Jun 202420.41%17.04
28 Jun 202421.02%19.71
15 Jul 202421.85%29.87
31 Jul 202421.31%19.7110-Q filed, results (8-K)
15 Aug 202420.66%23.20
30 Aug 202421.14%45.74
13 Sep 202420.77%42.46
30 Sep 202420.59%19.24
15 Oct 202419.79%24.16
31 Oct 202417.94%14.8610-Q filed, results (8-K)
15 Nov 202417.51%15.68
29 Nov 202416.27%23.30
13 Dec 202415.00%18.75
31 Dec 202415.23%19.34

See also: CORCEPT THERAPEUTICS INC's full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.